237 related articles for article (PubMed ID: 31439922)
1. Crystal structures of cholera toxin in complex with fucosylated receptors point to importance of secondary binding site.
Heim JB; Hodnik V; Heggelund JE; Anderluh G; Krengel U
Sci Rep; 2019 Aug; 9(1):12243. PubMed ID: 31439922
[TBL] [Abstract][Full Text] [Related]
2. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
Kirkeby S; Lynge Pedersen AM
Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.
Merritt EA; Sarfaty S; van den Akker F; L'Hoir C; Martial JA; Hol WG
Protein Sci; 1994 Feb; 3(2):166-75. PubMed ID: 8003954
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of blood group antigen binding to classical and El Tor cholera toxin B-pentamers by NMR.
Vasile F; Reina JJ; Potenza D; Heggelund JE; Mackenzie A; Krengel U; Bernardi A
Glycobiology; 2014 Aug; 24(8):766-78. PubMed ID: 24829308
[TBL] [Abstract][Full Text] [Related]
5. A single native ganglioside GM1-binding site is sufficient for cholera toxin to bind to cells and complete the intoxication pathway.
Jobling MG; Yang Z; Kam WR; Lencer WI; Holmes RK
mBio; 2012 Oct; 3(6):. PubMed ID: 23111873
[TBL] [Abstract][Full Text] [Related]
6. Variation in epitopes of the B subunit of Vibrio cholerae non-O1 and Vibrio mimicus cholera toxins.
Tamplin ML; Jalali R; Ahmed MK; Colwell RR
Can J Microbiol; 1990 Jun; 36(6):409-13. PubMed ID: 1697780
[TBL] [Abstract][Full Text] [Related]
7. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
Blanco LP; DiRita VJ
Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
[TBL] [Abstract][Full Text] [Related]
8. Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array.
Worstell NC; Krishnan P; Weatherston JD; Wu HJ
PLoS One; 2016; 11(4):e0153265. PubMed ID: 27070150
[TBL] [Abstract][Full Text] [Related]
9. Towards new cholera prophylactics and treatment: Crystal structures of bacterial enterotoxins in complex with GM1 mimics.
Heggelund JE; Mackenzie A; Martinsen T; Heim JB; Cheshev P; Bernardi A; Krengel U
Sci Rep; 2017 May; 7(1):2326. PubMed ID: 28539625
[TBL] [Abstract][Full Text] [Related]
10. Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera.
Kuhlmann FM; Santhanam S; Kumar P; Luo Q; Ciorba MA; Fleckenstein JM
Am J Trop Med Hyg; 2016 Aug; 95(2):440-3. PubMed ID: 27162272
[TBL] [Abstract][Full Text] [Related]
11. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
Yu RK; Usuki S; Itokazu Y; Wu HC
Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
[TBL] [Abstract][Full Text] [Related]
12. The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition.
Margheri G; D'Agostino R; Trigari S; Sottini S; Del Rosso M
Lipids; 2014 Feb; 49(2):203-6. PubMed ID: 24122042
[TBL] [Abstract][Full Text] [Related]
13. Insights into binding of cholera toxin to GM1 containing membrane.
Basu I; Mukhopadhyay C
Langmuir; 2014 Dec; 30(50):15244-52. PubMed ID: 25425333
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit.
Mertz JA; McCann JA; Picking WD
Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera.
Das S; Angsantikul P; Le C; Bao D; Miyamoto Y; Gao W; Zhang L; Eckmann L
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006266. PubMed ID: 29470490
[TBL] [Abstract][Full Text] [Related]
16. Association of Vibrio cholerae 569B outer membrane vesicles with host cells occurs in a GM1-independent manner.
Rasti ES; Schappert ML; Brown AC
Cell Microbiol; 2018 Jun; 20(6):e12828. PubMed ID: 29377560
[TBL] [Abstract][Full Text] [Related]
17. Multi-scale molecular dynamics study of cholera pentamer binding to a GM1-phospholipid membrane.
Sridhar A; Kumar A; Dasmahapatra AK
J Mol Graph Model; 2016 Jul; 68():236-251. PubMed ID: 27474868
[TBL] [Abstract][Full Text] [Related]
18. A 'catch-and-release' receptor for the cholera toxin.
Mahon CS; Wildsmith GC; Haksar D; de Poel E; Beekman JM; Pieters RJ; Webb ME; Turnbull WB
Faraday Discuss; 2019 Oct; 219(0):112-127. PubMed ID: 31313796
[TBL] [Abstract][Full Text] [Related]
19. Cholera: pathophysiology and emerging therapeutic targets.
Muanprasat C; Chatsudthipong V
Future Med Chem; 2013 May; 5(7):781-98. PubMed ID: 23651092
[TBL] [Abstract][Full Text] [Related]
20. A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity.
Aman AT; Fraser S; Merritt EA; Rodigherio C; Kenny M; Ahn M; Hol WG; Williams NA; Lencer WI; Hirst TR
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8536-41. PubMed ID: 11447291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
